The Real opportunity: capitalising on Brazil's push to provide quality healthcare
This article was originally published in Clinica
Executive Summary
Calling on a government to ring-fence funding for key health services might not seem exceptional. But when an influential Brazilian parliamentary committee demands that US$3.4bn – one-tenth of the annual federal healthcare budget – be set aside for medtech-intensive priorities, it's a different matter. This is just one indication of the scale of healthcare demand in Brazil and the strong political force that is driving the opportunities in this market. Bernard Murphy reports
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.